title: Chinese medicine injection shuanghuanglian for treatment of acute upper respiratory tract infection: a systematic review of randomized controlled trials.
abstract: Acute upper respiratory tract infections (AURTIs) are the illnesses caused by an acute infection with various viruses and bacteria involving the upper respiratory tract. Shuanghuanglian (SHL) injection, a Chinese medicine intravenous preparation extracted from honeysuckle, Scutellaria baicalensis, and fructus forsythiae, is commonly used to treat AURTIs. Although it is used largely in Chinese hospitals, there is no substantial evidence to demonstrate its clinical effect on AURTIs. We conducted a systematic review to evaluate the effectiveness and safety of Shuanghuanglian injection for the treatment of acute upper respiratory tract infections.
authors.affiliation: School of Chinese Medicine, Faculty of Science, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
authors.forename: Hongwei
authors.initials: H
authors.lastname: Zhang
authors.forename: Qin
authors.initials: Q
authors.lastname: Chen
authors.forename: Weiwei
authors.initials: W
authors.lastname: Zhou
authors.forename: Shi
authors.initials: S
authors.lastname: Gao
authors.forename: Huiguang
authors.initials: H
authors.lastname: Lin
authors.forename: Shuifen
authors.initials: S
authors.lastname: Ye
authors.forename: Yihui
authors.initials: Y
authors.lastname: Xu
authors.forename: Jing
authors.initials: J
authors.lastname: Cai